Achillion Announces the Promotion of Milind S. Deshpande, Ph.D. to Executive Vice President of Research

13-Jun-2007

Achillion Pharmaceuticals, Inc. announced that Milind Deshpande, Ph.D. has been promoted to Executive Vice President of Research. Dr. Deshpande previously served as the Company's Senior Vice President, and retains his position as Chief Scientific Officer.

Dr. Deshpande joined Achillion as Vice President of Chemistry in September 2001. He was named Head of Drug Discovery in April 2002, and promoted to Vice President of Drug Discovery in December 2002. Prior to joining Achillion, Dr. Deshpande was Associate Director in Chemistry at the Pharmaceutical Research Institute at Bristol-Myers Squibb, where he managed the identification of new clinical candidates to treat infectious and neurological diseases. Before that, Dr. Deshpande held a faculty position at Boston University Medical School. Following his undergraduate education in India, Dr. Deshpande received his Ph.D. in Organic Chemistry from Ohio University.

In May 2007, Dr. Deshpande temporarily assumed leadership of Achillion's clinical development activities upon the resignation of John Pottage, Jr., M.D., as Senior Vice President and Chief Medical Officer. He will retain these responsibilities while the Company continues its search for a new chief medical officer.

Other news from the department people

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance